Skip to Main Content
American Flag
JULY 4TH SALE

50% off your first year of Quiver Premium

...

Use Promo Code:

JULY4
American Flag

Edwards Lifesciences Corp

EW Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of EW by members of U.S. Congress

Politician Type Traded
Jefferson Shreve House / R Sale $50,001 - $100,000 May 12, 2025
Bruce Westerman House / R Sale $1,001 - $15,000 Apr 21, 2025
Robert Bresnahan House / R Purchase $1,001 - $15,000 Apr 08, 2025
Jefferson Shreve House / R Purchase $15,001 - $50,000 Apr 07, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 12, 2025
Bruce Westerman House / R Purchase $1,001 - $15,000 Mar 03, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 12, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Byron Donalds House / R Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Markwayne Mullin Senate / R Sale (Partial) $15,001 - $50,000 Aug 20, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Aug 02, 2024
Mike Kelly House / R Sale $1,001 - $15,000 Apr 11, 2024
Ro Khanna House / D Purchase None N/A
Josh Gottheimer House / D Purchase $1,001 - $15,000 Dec 11, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Dec 05, 2023
John R. Curtis House / R Sale $1,001 - $15,000 Dec 04, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Nov 06, 2023
Ro Khanna House / D Sale $15,001 - $50,000 Nov 06, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Nov 03, 2023
Byron Donalds House / R Sale $1,001 - $15,000 Oct 19, 2023
Byron Donalds House / R Sale $1,001 - $15,000 Oct 19, 2023
Markwayne Mullin Senate / R Purchase $1,001 - $15,000 Oct 03, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Oct 02, 2023
Markwayne Mullin Senate / R Purchase $15,001 - $50,000 Sep 13, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 05, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 29, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Jul 28, 2023
John R. Curtis House / R Purchase $1,001 - $15,000 Jun 21, 2023
Zoe Lofgren House / D Sale $1,001 - $15,000 May 25, 2023
John R. Curtis House / R Purchase $1,001 - $15,000 Apr 26, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Apr 25, 2023
Tommy Tuberville Senate / R Sale (Full) $1,001 - $15,000 Apr 03, 2023
Daniel S. Goldman House / D Purchase $15,001 - $50,000 Mar 06, 2023
Diana Harshbarger House / R Purchase $1,001 - $15,000 Jan 25, 2023
Diana Harshbarger House / R Purchase $1,001 - $15,000 Jan 25, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Dec 02, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 03, 2022
Diana Harshbarger House / R Purchase $1,001 - $15,000 Oct 27, 2022
Diana Harshbarger House / R Purchase $1,001 - $15,000 Oct 27, 2022
Diana Harshbarger House / R Purchase $1,001 - $15,000 Oct 27, 2022
Diana Harshbarger House / R Purchase $1,001 - $15,000 Oct 27, 2022
Ro Khanna House / D Sale $1,001 - $15,000 Sep 29, 2022
Ro Khanna House / D Sale None Sep 29, 2022
Ro Khanna House / D Purchase $15,001 - $50,000 Sep 08, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 06, 2022
Ro Khanna House / D Sale $1,001 - $15,000 Aug 23, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 19, 2022
EW Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
EW Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
EW Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by EW's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions
  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $350,000 Apr 18, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign) Veterans
  • $390,000 Jan 17, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $350,000 Oct 18, 2024 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $370,000 Aug 26, 2024 Issue: Veterans Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $380,000 Jul 18, 2024 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $430,000 Apr 18, 2024 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $50,000 Jan 22, 2024 Issue: Health Issues Medicare/Medicaid
  • $60,000 Jan 22, 2024 Issue: Health Issues Medicare/Medicaid
  • $330,000 Oct 17, 2023 Issue: Veterans Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $350,000 Jan 17, 2023 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $310,000 Oct 20, 2022 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $330,000 Jul 20, 2022 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $380,000 Apr 27, 2022 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $260,000 Apr 20, 2022 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $340,000 Jan 20, 2022 Issue: None
  • $290,000 Oct 20, 2021 Issue: None
  • $240,000 Jul 20, 2021 Issue: None
  • $240,000 Apr 19, 2021 Issue: None
  • $310,000 Jan 20, 2021 Issue: None
  • $230,000 Oct 19, 2020 Issue: None
  • $360,000 Jul 20, 2020 Issue: None
  • $340,000 Apr 20, 2020 Issue: None
  • $340,000 Jan 21, 2020 Issue: None
  • $250,000 Oct 21, 2019 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $380,000 Jul 19, 2019 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $350,000 Jul 19, 2019 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $310,000 May 13, 2019 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $250,000 Oct 08, 2018 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $390,000 Jul 31, 2018 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $320,000 Jul 20, 2018 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $210,000 Apr 16, 2018 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $190,000 Oct 20, 2017 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $250,000 Jul 20, 2017 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $230,000 Apr 17, 2017 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $180,000 Jan 17, 2017 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $220,000 Oct 20, 2016 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $230,000 Jul 20, 2016 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $320,000 Apr 19, 2016 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $190,000 Jan 19, 2016 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $210,000 Oct 20, 2015 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $260,000 Jul 20, 2015 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $340,000 Apr 17, 2015 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $200,000 Jan 19, 2015 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $210,000 Oct 20, 2014 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Veterans
  • $230,000 Jul 18, 2014 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Veterans Medicare/Medicaid
  • $250,000 Apr 21, 2014 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $220,000 Jan 21, 2014 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $210,000 Oct 21, 2013 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $300,000 Jul 19, 2013 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid Trade (domestic/foreign)
  • $360,000 Apr 19, 2013 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $280,000 Jan 18, 2013 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $270,000 Oct 18, 2012 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $240,000 Jul 20, 2012 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $360,000 Apr 20, 2012 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $230,000 Jan 19, 2012 Issue: Medical/Disease Research/Clinical Labs Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $250,000 Oct 20, 2011 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues Taxation/Internal Revenue Code
  • $290,000 Jul 20, 2011 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $320,000 Apr 20, 2011 Issue: Medicare/Medicaid Copyright/Patent/Trademark Health Issues Medical/Disease Research/Clinical Labs Taxation/Internal Revenue Code Transportation
  • $240,000 Jan 20, 2011 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $210,000 Oct 20, 2010 Issue: Medical/Disease Research/Clinical Labs Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $250,000 Jul 19, 2010 Issue: Torts Medical/Disease Research/Clinical Labs Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $290,000 Apr 19, 2010 Issue: Torts Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $240,000 Jan 20, 2010 Issue: Torts Medical/Disease Research/Clinical Labs Health Issues Trade (domestic/foreign) Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $240,000 Oct 19, 2009 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Torts Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $300,000 Jul 20, 2009 Issue: Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Trade (domestic/foreign) Medicare/Medicaid Medical/Disease Research/Clinical Labs Torts
  • $180,000 Apr 28, 2009 Issue: Medicare/Medicaid Health Issues Budget/Appropriations
  • $270,000 Apr 28, 2009 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs Copyright/Patent/Trademark Trade (domestic/foreign) Agriculture Health Issues Budget/Appropriations
  • $115,817 Oct 20, 2008 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $178,357 Aug 13, 2008 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid Agriculture Copyright/Patent/Trademark Trade (domestic/foreign) Health Issues
  • $141,053 Jul 21, 2008 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Medical/Disease Research/Clinical Labs
  • $186,280 Feb 14, 2008 Issue: Trade (domestic/foreign) Agriculture Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations
  • $118,278 Aug 07, 2007 Issue: Trade (domestic/foreign) Health Issues Medicare/Medicaid Budget/Appropriations
  • $98,785 Jan 30, 2007 Issue: Medicare/Medicaid Agriculture
  • $93,556 Aug 08, 2006 Issue: Agriculture Medicare/Medicaid
  • $21,000 Feb 24, 2006 Issue: Trade (domestic/foreign) Medicare/Medicaid
  • $20,000 Nov 21, 2005 Issue: Trade (domestic/foreign) Medicare/Medicaid
  • $117,500 Aug 17, 2005 Issue: Trade (domestic/foreign) Medicare/Medicaid

Estimated quarterly lobbying spending

EW Revenue by Segment or Geography

By Segment
By Geography
EW Income Statement
EW Balance Sheet
EW Cash Flow
U.S. Patents

New patents grants

  • Patent Title: Delivery systems for prosthetic heart valve Apr. 08, 2025
  • Patent Title: Mechanically expandable prosthetic heart valve and delivery apparatus Apr. 08, 2025
  • Patent Title: Valve anchor and installation method Apr. 08, 2025
  • Patent Title: Combined introducer and expandable sheath Apr. 01, 2025
  • Patent Title: Method for delivering a prosthetic heart valve Apr. 01, 2025
  • Patent Title: Retaining mechanisms for prosthetic valves Mar. 25, 2025
  • Patent Title: Suture deployment of prosthetic heart valve Mar. 25, 2025
  • Patent Title: Purse-string sutures Mar. 25, 2025
  • Patent Title: Device and method for treating vascular insufficiency Mar. 18, 2025
  • Patent Title: Multiple-firing suture fixation device and methods for using and manufacturing same Mar. 18, 2025
  • Patent Title: Deployment tools and methods for delivering a device to a native heart valve Mar. 11, 2025
  • Patent Title: Cardiac valve repair devices configured for percutaneous delivery Mar. 11, 2025
  • Patent Title: Percutaneous implant retrieval methods Mar. 11, 2025
  • Patent Title: Devices for assisting with heart valve manufacturing Mar. 11, 2025
  • Patent Title: Methods for treating a deficient native mitral valve Mar. 11, 2025
  • Patent Title: Transcatheter heart valve leaflet plication Mar. 11, 2025
  • Patent Title: Unidirectional valvular implant Mar. 11, 2025
  • Patent Title: Prosthetic heart valve packaging Mar. 04, 2025
  • Patent Title: Knotless suture fastener installation system Mar. 04, 2025
  • Patent Title: Mitral valve spacer device Feb. 25, 2025
  • Patent Title: Prosthetic heart valve leaflet assemblies and methods Feb. 25, 2025
  • Patent Title: Automated heart valve manufacturing Feb. 18, 2025
  • Patent Title: Prosthetic heart valve Feb. 18, 2025
  • Patent Title: Heart valve stents adapted for post-implant expansion Feb. 18, 2025
  • Patent Title: Heart valve sealing devices and delivery devices therefor Feb. 11, 2025
  • Patent Title: Expandable sheath and methods of using the same Feb. 04, 2025
  • Patent Title: Constricting a cardiac valve annulus using a cord that has a loop portion and a single second portion Jan. 28, 2025
  • Patent Title: Implant delivery capsule Jan. 28, 2025
  • Patent Title: Heart valve dysfunction detection Jan. 28, 2025
  • Patent Title: Method for sterilizing heart valves Jan. 21, 2025
  • Patent Title: Mechanically expandable heart valve Jan. 21, 2025
  • Patent Title: Prosthetic heart valve Jan. 21, 2025
  • Patent Title: Prosthetic valve Jan. 21, 2025
  • Patent Title: Expandable sheath Jan. 14, 2025
  • Patent Title: Covered prosthetic heart valve Jan. 14, 2025
  • Patent Title: Suture clips, deployment devices therefor, and methods of use Jan. 14, 2025
  • Patent Title: Heart valve sealing devices and delivery devices therefor Jan. 07, 2025
  • Patent Title: Methods of forming heat set annuloplasty rings Jan. 07, 2025
  • Patent Title: Prosthetic heart valve Jan. 07, 2025
  • Patent Title: Docking stations for transcatheter valves Jan. 07, 2025
  • Patent Title: Prosthetic heart valve delivery apparatus Jan. 07, 2025
  • Patent Title: Valved conduit Jan. 07, 2025
  • Patent Title: Balloon cover for a delivery apparatus for an expandable prosthetic heart valve Jan. 07, 2025
  • Patent Title: Semi-automatic precision positioning robot apparatus and method Jan. 07, 2025
  • Patent Title: Heart valve docking coil Jan. 07, 2025
  • Patent Title: Apparatus for the introduction and manipulation of multiple telescoping catheters Dec. 31, 2024
  • Patent Title: Chordae tendineae adjustment Dec. 31, 2024
  • Patent Title: Method for directing cellular migration patterns on a biological tissue Dec. 31, 2024
  • Patent Title: Multi-frame prosthetic heart valve Dec. 31, 2024
  • Patent Title: Methods and systems for aligning a commissure of a prosthetic heart valve with a commissure of a native valve Dec. 24, 2024
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

EW News

Recent insights relating to EW

CNBC Recommendations

Recent picks made for EW stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in EW

EW Analyst Ratings

EW Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
EW Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $EW stock a Buy, Sell, or Hold?

  • What is the price target for $EW stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

EW Top Shareholders
Shareholder
Shares Held
EW Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $EW stock?

  • Who owns the most shares of $EW stock?

  • What funds own $EW stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

EW Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view EW Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top